Wanqing Xie

427 total citations
19 papers, 304 citations indexed

About

Wanqing Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wanqing Xie has authored 19 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Wanqing Xie's work include Osteoarthritis Treatment and Mechanisms (3 papers), Cancer Genomics and Diagnostics (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Wanqing Xie is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (3 papers), Cancer Genomics and Diagnostics (3 papers) and Wnt/β-catenin signaling in development and cancer (3 papers). Wanqing Xie collaborates with scholars based in China, United States and Italy. Wanqing Xie's co-authors include Di Chen, Tianqian Hui, Shan Li, Meiqing Wang, Jia Li, Qiang Mao, Philip Babij, Yan Sun, Baoli Wang and Hongting Jin and has published in prestigious journals such as Journal of Clinical Investigation, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Wanqing Xie

17 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanqing Xie China 11 145 85 60 43 33 19 304
Yukihiro Kohara Japan 10 126 0.9× 79 0.9× 52 0.9× 31 0.7× 16 0.5× 22 292
Claire-Sophie Devignes France 6 158 1.1× 81 1.0× 77 1.3× 80 1.9× 21 0.6× 8 308
Gareth Hyde United Kingdom 6 122 0.8× 91 1.1× 55 0.9× 30 0.7× 13 0.4× 8 280
Mustapha Zeddou Belgium 11 143 1.0× 58 0.7× 48 0.8× 39 0.9× 42 1.3× 17 353
Maya Fakhry Lebanon 5 177 1.2× 59 0.7× 48 0.8× 77 1.8× 10 0.3× 6 354
Manli Tu China 6 146 1.0× 161 1.9× 31 0.5× 45 1.0× 27 0.8× 6 323
Liqiang Zhi China 12 210 1.4× 74 0.9× 55 0.9× 120 2.8× 23 0.7× 32 344
Dengwei He China 15 170 1.2× 98 1.2× 39 0.7× 79 1.8× 73 2.2× 41 608
Kyung‐Eun Lim South Korea 12 261 1.8× 57 0.7× 115 1.9× 37 0.9× 18 0.5× 21 420
Zenong Yuan China 10 171 1.2× 52 0.6× 34 0.6× 69 1.6× 11 0.3× 21 317

Countries citing papers authored by Wanqing Xie

Since Specialization
Citations

This map shows the geographic impact of Wanqing Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanqing Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanqing Xie more than expected).

Fields of papers citing papers by Wanqing Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanqing Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanqing Xie. The network helps show where Wanqing Xie may publish in the future.

Co-authorship network of co-authors of Wanqing Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Wanqing Xie. A scholar is included among the top collaborators of Wanqing Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanqing Xie. Wanqing Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lü, Xiaodong, Wanqing Xie, Galina Gritsina, et al.. (2025). NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling. Nature Genetics. 57(8). 1966–1980. 1 indexed citations
2.
Hu, Qing, Xun Wu, Wanqing Xie, et al.. (2025). Adiponectin ameliorates traumatic brain injury-induced ferroptosis through AMPK- ACC1 signaling pathway. Brain Behavior and Immunity. 126. 160–175. 3 indexed citations
3.
Liu, Wei, Qianqian Huang, Shangshang Wang, et al.. (2025). Single‐cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia. British Journal of Haematology. 207(4). 1309–1322.
4.
Xie, Wanqing, Jing Hu, Qiao Mei, et al.. (2023). Deep learning–based lesion detection and severity grading of small-bowel Crohn’s disease ulcers on double-balloon endoscopy images. Gastrointestinal Endoscopy. 99(5). 767–777.e5. 11 indexed citations
5.
Gritsina, Galina, Ka-wing Fong, Xiaodong Lü, et al.. (2023). Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth. Journal of Clinical Investigation. 133(15). 17 indexed citations
6.
Wang, Xiaohai, Xiaodong Lü, Galina Gritsina, et al.. (2022). FOXA1 inhibits hypoxia programs through transcriptional repression of HIF1A. Oncogene. 41(37). 4259–4270. 14 indexed citations
7.
Fan, Yunshan, Lan Zhao, Wanqing Xie, et al.. (2019). Serum miRNAs are potential biomarkers for the detection of disc degeneration, among which miR‐26a‐5p suppresses Smad1 to regulate disc homeostasis. Journal of Cellular and Molecular Medicine. 23(10). 6679–6689. 12 indexed citations
8.
Xie, Wanqing, Yongjian Zhao, Feng Li, et al.. (2019). Velvet antler polypeptide partially rescue facet joint osteoarthritis-like phenotype in adult β-catenin conditional activation mice. BMC Complementary and Alternative Medicine. 19(1). 191–191. 14 indexed citations
9.
Xie, Wanqing, et al.. (2015). Assessment of The Quality of Life In Chinese Myasthenia Gravis Patients. Value in Health. 18(3). A155–A155. 1 indexed citations
10.
Han, Tao, Yaling Han, Wanqing Xie, et al.. (2015). High expression of UBD correlates with epirubicin resistance and indicates poor prognosis in triple-negative breast cancer. OncoTargets and Therapy. 8. 1643–1643. 13 indexed citations
11.
Xie, Wanqing, et al.. (2015). Wnt/β‐catenin signaling plays a key role in the development of spondyloarthritis. Annals of the New York Academy of Sciences. 1364(1). 25–31. 46 indexed citations
12.
Jin, Hongting, Baoli Wang, Jia Li, et al.. (2014). Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling. Bone. 71. 63–75. 75 indexed citations
13.
Chen, Michael, et al.. (2014). Col2CreERT2, a mouse model for a chondrocyte-specific and inducible gene deletion. European Cells and Materials. 28. 236–245. 14 indexed citations
14.
Wang, Meiqing, Wanqing Xie, Jie Shen, et al.. (2014). Activation of β-catenin signalling leads to temporomandibular joint defects. European Cells and Materials. 28. 223–235. 32 indexed citations
15.
Zhang, Guojing, Wanqing Xie, Chao Lin, et al.. (2014). Prognostic Function of Ki-67 for Pathological Complete Response Rate of Neoadjuvant Chemotherapy in Triple-negative Breast Cancer. Tumori Journal. 100(2). 136–142. 8 indexed citations
16.
Zhou, Qiang, Xinyan Chen, Shuiping Zhou, et al.. (2014). Chinese Herbal Medicine for Obesity: A Randomized, Double-Blinded, Multicenter, Prospective Trial. The American Journal of Chinese Medicine. 42(6). 1345–1356. 31 indexed citations
17.
Hou, Zhongsheng, et al.. (2013). An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion. SHILAP Revista de lepidopterología. 10 indexed citations
18.
Zhang, Guojing, et al.. (2013). Predictors of neoadjuvant chemotherapy for triple-negative breast cancer: a meta-analysis with 723 cases. The Chinese-German Journal of Clinical Oncology. 12(1). 15–19. 1 indexed citations
19.
Hu, Yue, et al.. (1999). [Neurilemmoma of the nasal cavity and paranasal sinuses (report of 12 cases)].. PubMed. 13(9). 409–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026